I said the CN was good depending on the release of the clinical trial updates for VAXINIA and especially OASIS (the FPI for monotherapy is approaching 18 months which was when the clinical trial update for VAXINIA got release), there's still 3 months to go before the conversion price is calculated and given the amount of R&D they've spent in the last 2 years for OASIS and VAXINIA, I'm expecting clinical trial updates from them.......
IMU Price at posting:
2.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)